EPRSQ : EPIRUS Biopharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-01-14 |
|---|---|---|---|---|
| 2022 | $0.0 | $0.0 | $0.0 | -26.98% |
| 2023 | $0.0 | $0.0 | $0.0 | -38.45% |
| 2024 | $0.0 | $0.0 | $0.0 | -47.58% |
| 2025 | $0.0 | $0.0 | $0.0 | -52.42% |
| 2026 | $0.0 | $0.0 | $0.0 | -66.65% |
| 2027 | $0.0 | $0.0 | $0.0 | -20.4% |
| 2028 | $0.0 | $0.0 | $0.0 | -47.84% |
| 2029 | $0.0 | $0.0 | $0.0 | -52.08% |
| 2030 | $0.0 | $0.0 | $0.0 | -56.41% |
| 2031 | $0.0 | $0.0 | $0.0 | -61.81% |
| 2032 | $0.0 | $0.0 | $0.0 | -59.86% |
From AI system, total return is 3138.37% from 3070 forecasts.
For EPIRUS Biopharmaceuticals stock forecast for 2022, 11 predictions are offered for each month of 2022 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2022 represents a -26.98%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2023, 12 predictions are offered for each month of 2023 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2023 represents a -38.45%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2025, 12 predictions are offered for each month of 2025 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2025 represents a -52.42%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2027 represents a -20.4%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2030, 12 predictions are offered for each month of 2030 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2030 represents a -56.41%
decrease from the last price of $9.99999974737875E-5.
For EPIRUS Biopharmaceuticals stock forecast for 2032 (10 year), 1 predictions are offered for each month of 2032 with average EPIRUS Biopharmaceuticals stock
forecast of $0.0, a high forecast of $0.0, and a low forecast of $0.0.
The average EPIRUS Biopharmaceuticals stock forecast 2032 represents a -59.86%
decrease from the last price of $9.99999974737875E-5.
Please, see more forecasts below.
EPIRUS Biopharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2021-11-22 | $.00 | 6.01% |
| 2021-11-23 | $.00 | 136.32% |
| 2021-11-24 | $.00 | 40.85% |
| 2021-11-25 | $.00 | -11.12% |
| 2021-11-26 | $.00 | -19.90% |
EPRSQ : Long term EPIRUS Biopharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Feb. is $.00 , for 2023 Jan. is $.00 , for 2026 Jan. is $.00 , for 2027 Jan. is $.00 , for 2031 Jan. is $.00 , and for 2032 Jan. is $.00.
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Feb. | $.00 | -0.15% |
| 2022 Mar. | $.00 | -1.75% |
| 2022 Apr. | $.00 | -8.46% |
| 2022 May. | $.00 | -25.92% |
| 2022 Jun. | $.00 | -15.09% |
| 2022 Jul. | $.00 | 2.50% |
| 2022 Aug. | $.00 | 7.03% |
| 2022 Sep. | $.00 | 5.48% |
| 2022 Oct. | $.00 | 3.17% |
| 2022 Nov. | $.00 | 2.25% |
| 2022 Dec. | $.00 | 2.82% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $.00 | 12.43% |
| 2023 Feb. | $.00 | -1.82% |
| 2023 Mar. | $.00 | -6.83% |
| 2023 Apr. | $.00 | -7.72% |
| 2023 May. | $.00 | -5.55% |
| 2023 Jun. | $.00 | -1.14% |
| 2023 Jul. | $.00 | -4.90% |
| 2023 Aug. | $.00 | -4.78% |
| 2023 Sep. | $.00 | -6.10% |
| 2023 Oct. | $.00 | -6.58% |
| 2023 Nov. | $.00 | -5.17% |
| 2023 Dec. | $.00 | -1.13% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $.00 | 3.78% |
| 2024 Feb. | $.00 | 3.74% |
| 2024 Mar. | $.00 | 3.76% |
| 2024 Apr. | $.00 | 3.11% |
| 2024 May. | $.00 | 1.94% |
| 2024 Jun. | $.00 | -1.08% |
| 2024 Jul. | $.00 | -4.23% |
| 2024 Aug. | $.00 | -1.45% |
| 2024 Sep. | $.00 | 0.94% |
| 2024 Oct. | $.00 | 1.45% |
| 2024 Nov. | $.00 | 1.43% |
| 2024 Dec. | $.00 | 0.94% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $.00 | -1.04% |
| 2025 Feb. | $.00 | -4.00% |
| 2025 Mar. | $.00 | 11.36% |
| 2025 Apr. | $.00 | 0.43% |
| 2025 May. | $.00 | -5.58% |
| 2025 Jun. | $.00 | -3.22% |
| 2025 Jul. | $.00 | -5.13% |
| 2025 Aug. | $.00 | -6.31% |
| 2025 Sep. | $.00 | -6.92% |
| 2025 Oct. | $.00 | -8.50% |
| 2025 Nov. | $.00 | -9.37% |
| 2025 Dec. | $.00 | -10.48% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $.00 | -10.24% |
| 2026 Feb. | $.00 | -7.88% |
| 2026 Mar. | $.00 | -3.75% |
| 2026 Apr. | $.00 | 5.03% |
| 2026 May. | $.00 | 7.73% |
| 2026 Jun. | $.00 | 6.86% |
| 2026 Jul. | $.00 | 5.68% |
| 2026 Aug. | $.00 | 5.44% |
| 2026 Sep. | $.00 | 5.91% |
| 2026 Oct. | $.00 | 6.89% |
| 2026 Nov. | $.00 | 9.13% |
| 2026 Dec. | $.00 | 13.08% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $.00 | 15.10% |
| 2027 Feb. | $.00 | 15.20% |
| 2027 Mar. | $.00 | 11.89% |
| 2027 Apr. | $.00 | 8.21% |
| 2027 May. | $.00 | 4.74% |
| 2027 Jun. | $.00 | 2.97% |
| 2027 Jul. | $.00 | 2.34% |
| 2027 Aug. | $.00 | 1.93% |
| 2027 Sep. | $.00 | 1.34% |
| 2027 Oct. | $.00 | 0.55% |
| 2027 Nov. | $.00 | -0.20% |
| 2027 Dec. | $.00 | -0.92% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $.00 | -1.77% |
| 2028 Feb. | $.00 | -3.12% |
| 2028 Mar. | $.00 | -6.42% |
| 2028 Apr. | $.00 | -12.26% |
| 2028 May. | $.00 | -19.88% |
| 2028 Jun. | $.00 | -26.28% |
| 2028 Jul. | $.00 | -20.99% |
| 2028 Aug. | $.00 | -3.81% |
| 2028 Sep. | $.00 | 6.03% |
| 2028 Oct. | $.00 | 11.08% |
| 2028 Nov. | $.00 | 12.69% |
| 2028 Dec. | $.00 | 7.57% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $.00 | 6.78% |
| 2029 Feb. | $.00 | 5.97% |
| 2029 Mar. | $.00 | 5.30% |
| 2029 Apr. | $.00 | 4.58% |
| 2029 May. | $.00 | 3.25% |
| 2029 Jun. | $.00 | -2.02% |
| 2029 Jul. | $.00 | -9.64% |
| 2029 Aug. | $.00 | -12.98% |
| 2029 Sep. | $.00 | -8.38% |
| 2029 Oct. | $.00 | -0.08% |
| 2029 Nov. | $.00 | 6.13% |
| 2029 Dec. | $.00 | 8.25% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $.00 | 6.39% |
| 2030 Feb. | $.00 | 3.33% |
| 2030 Mar. | $.00 | 0.23% |
| 2030 Apr. | $.00 | -2.61% |
| 2030 May. | $.00 | -4.46% |
| 2030 Jun. | $.00 | -5.14% |
| 2030 Jul. | $.00 | -5.44% |
| 2030 Aug. | $.00 | -5.16% |
| 2030 Sep. | $.00 | -3.68% |
| 2030 Oct. | $.00 | -2.10% |
| 2030 Nov. | $.00 | -0.25% |
| 2030 Dec. | $.00 | 3.77% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $.00 | 9.39% |
| 2031 Feb. | $.00 | 13.08% |
| 2031 Mar. | $.00 | 10.65% |
| 2031 Apr. | $.00 | 0.88% |
| 2031 May. | $.00 | -9.68% |
| 2031 Jun. | $.00 | -16.12% |
| 2031 Jul. | $.00 | -19.05% |
| 2031 Aug. | $.00 | -18.22% |
| 2031 Sep. | $.00 | -9.66% |
| 2031 Oct. | $.00 | 3.56% |
| 2031 Nov. | $.00 | 13.56% |
| 2031 Dec. | $.00 | 18.81% |
EPRSQ : EPIRUS Biopharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $.00 | 18.19% |
Financial Data for EPIRUS Biopharmaceuticals stock
Frequently Asked Questions about EPIRUS Biopharmaceuticals stock forecast
Is EPIRUS Biopharmaceuticals a good long term stock?
From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2022 Feb. is $9.98465927784517E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2023 Jan. is $7.97010056113941E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2026 Jan. is $2.87799287444792E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2027 Jan. is $5.52881447126991E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2031 Jan. is $4.24982783633672E-5 From EPIRUS Biopharmaceuticals stock forecast , EPIRUS Biopharmaceuticals (EPRSQ) stock cannot be a good investment choice. According to AI Pickup, the EPIRUS Biopharmaceuticals stock price forecast for 2032 Jan. is $4.01370831662782E-5
Is EPIRUS Biopharmaceuticals stock overvalued?
EPIRUS Biopharmaceuticals (EPRSQ) stock is expected to go DOWN . Therefore, AI Pickup would say that EPIRUS Biopharmaceuticals (EPRSQ) stock is overvalued.
Will EPIRUS Biopharmaceuticals stock price go up?
No. The EPIRUS Biopharmaceuticals stock price forecast for 2023 Jan. is $7.97010056113941E-5
Is EPIRUS Biopharmaceuticals stock a good buy now?
Since closing price on 2022-01-14 is $9.99999974737875E-5 and forecast for 2023 Jan. is $.00, EPIRUS Biopharmaceuticals stock is not a good 1 year investment.